Aster Capital Management (Difc) LTD Corcept Therapeutics Inc Transaction History
Aster Capital Management (Difc) LTD
- $441 Billion
- Q2 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 3,128 shares of CORT stock, worth $275,733. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,128
Previous 1,794
74.36%
Holding current value
$275,733
Previous $109 Million
111.26%
% of portfolio
0.05%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding CORT
# of Institutions
467Shares Held
82.8MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.46 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$853 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$681 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$552 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$341 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $9.44B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...